1 / 6

Pregnancy and Prescription Medication Use Symposium – Round Table Discussion

This symposium features a round table discussion led by Tayo Fadiran, R.Ph., Ph.D., addressing critical topics in pregnancy and prescription medication use in clinical trials. Experts share insights on recruitment strategies, essential healthcare relationships, and experiences with Institutional Review Board (IRB) processes. Attendees will explore significant hurdles and future suggestions for pharmacokinetic studies in pregnant women. The presentation slides and webcast will be available on the FDA Women’s Health Research Home Page. Your feedback through the evaluation form is appreciated.

konane
Télécharger la présentation

Pregnancy and Prescription Medication Use Symposium – Round Table Discussion

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pregnancy and Prescription Medication Use Symposium – Round Table Discussion Tayo Fadiran, R.Ph., Ph.D.Senior Health Programs CoordinatorResearch & Development, OWH, FDA

  2. Discussion Questions • In giving advice to other researchers planning to conduct trials in pregnant women, what do you see as the most important elements? For example: • Recruitment strategies - what worked, what didn’t? • What healthcare provider/clinicians/clinics relationships were required for successful recruitment? • What was your experience with the IRB review of the proposal?

  3. Discussion Questions What are the greatest hurdles to the conduct of clinical trials in pregnant women? 

  4. Discussion Questions Do you have any specific suggestions for future PK studies in pregnant women?

  5. Discussion Questions What general recommendations do you have for future research in pregnant women?

  6. Presentation slides and web cast The presentation slides and the web cast of the symposium will be available soon at: FDA Women’s Health Research Home Page www.fda.gov/womenshealthresearch Please complete your evaluation form. Thanks!

More Related